- Home
- VIRT vs VKTX Comparison
VIRT vs VKTX Comparison
Compare VIRT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRT
- VKTX
- Stock Information
- Founded
- VIRT 2008
- VKTX 2012
- Country
- VIRT United States
- VKTX United States
- Employees
- VIRT N/A
- VKTX N/A
- Industry
- VIRT Investment Bankers/Brokers/Service
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- VIRT Finance
- VKTX Health Care
- Exchange
- VIRT Nasdaq
- VKTX Nasdaq
- Market Cap
- VIRT 3.5B
- VKTX 3.5B
- IPO Year
- VIRT 2015
- VKTX 2015
- Fundamental
- Price
- VIRT $35.67
- VKTX $23.82
- Analyst Decision
- VIRT Hold
- VKTX Strong Buy
- Analyst Count
- VIRT 8
- VKTX 12
- Target Price
- VIRT $39.75
- VKTX $87.50
- AVG Volume (30 Days)
- VIRT 1.1M
- VKTX 9.7M
- Earning Date
- VIRT 10-23-2025
- VKTX 10-22-2025
- Dividend Yield
- VIRT 2.71%
- VKTX N/A
- EPS Growth
- VIRT 122.21
- VKTX N/A
- EPS
- VIRT 4.40
- VKTX N/A
- Revenue
- VIRT $2,617,631,000.00
- VKTX N/A
- Revenue This Year
- VIRT N/A
- VKTX N/A
- Revenue Next Year
- VIRT N/A
- VKTX N/A
- P/E Ratio
- VIRT $8.05
- VKTX N/A
- Revenue Growth
- VIRT 42.88
- VKTX N/A
- 52 Week Low
- VIRT $29.82
- VKTX $18.92
- 52 Week High
- VIRT $45.77
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- VIRT 48.83
- VKTX 34.43
- Support Level
- VIRT N/A
- VKTX $24.82
- Resistance Level
- VIRT $38.85
- VKTX $26.50
- Average True Range (ATR)
- VIRT 1.01
- VKTX 1.13
- MACD
- VIRT -1.77
- VKTX -0.15
- Stochastic Oscillator
- VIRT 83.07
- VKTX 6.33
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.